Abstract
Objective markers of therapeutic deep brain stimulation (DBS) for Parkinson’s disease (PD) are needed to tailor stimulation on a patient-specific basis. Recent studies suggest that subthalamic nucleus DBS evoked resonant neural activity (ERNA) may be used to refine targeting and possibly identify therapeutic stimulation parameters [1]. However, ERNA has not been studied in the pallidum, and whether it could be used to guide intraoperative targeting or stimulation programming is unknown. We aimed to determine if ERNA is present with pallidal DBS and if pallidal ERNA features are correlated with baseline PD neurophysiology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
